{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:57:20Z","timestamp":1791050240897,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:00:00Z","timestamp":1706659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ajpath.2024.01.011","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T10:40:31Z","timestamp":1707129631000},"page":"772-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma"],"prefix":"10.1016","volume":"194","author":[{"given":"Bing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.01.011_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2024.01.011_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2024.01.011_bib3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/1078-0432.CCR-19-1068","article-title":"4-1BB agonism averts TIL exhaustion and licenses PD-1 blockade in glioblastoma and other intracranial cancers","volume":"26","author":"Woroniecka","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2024.01.011_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00401-022-02506-4","article-title":"The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers","volume":"144","author":"Tatari","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/neuonc\/noac250","article-title":"RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression","volume":"25","author":"Zhang","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1074\/mcp.M900243-MCP200","article-title":"Quantitative proteomics analysis of chondrogenic differentiation of C3H10T1\/2 mesenchymal stem cells by iTRAQ labeling coupled with on-line two-dimensional LC\/MS\/MS","volume":"9","author":"Ji","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2024.01.011_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semnephrol.2016.05.008","article-title":"The economic burden of chronic kidney disease and end-stage renal disease","volume":"36","author":"Wang","year":"2016","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3892\/ol.2016.4142","article-title":"Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2024.01.011_bib9","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1096\/fj.12-207530","article-title":"Uncovering genes required for neuronal morphology by morphology-based gene trap screening with a revertible retrovirus vector","volume":"26","author":"Hashimoto","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2024.01.011_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 Phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-021-00518-9","article-title":"The immune landscape of common CNS malignancies: implications for immunotherapy","volume":"18","author":"Ott","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2024.01.011_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","article-title":"Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity","volume":"40","author":"Chryplewicz","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.01.011_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/cas.15236","article-title":"Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples","volume":"113","author":"Di","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2024.01.011_bib16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/neuonc\/noab120","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications","volume":"23","author":"Wen","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974346","article-title":"TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker","volume":"13","author":"Ge","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2024.01.011_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1097-2765(03)00395-2","article-title":"Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes","volume":"12","author":"Rajasekhar","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2024.01.011_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2024.01.011_bib22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","article-title":"Suppression of anti-tumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate","volume":"24","author":"Bunse","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2024.01.011_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002181","article-title":"Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma","volume":"9","author":"Simonds","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajpath.2024.01.011_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2024.01.011_bib25","article-title":"Immunotherapy for glioblastoma: current progress and challenges","volume":"12","author":"Yu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","article-title":"Advances in the molecular genetics of gliomas\u2014implications for\u00a0classification and therapy","volume":"14","author":"Reifenberger","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/neuonc\/noaa154","article-title":"Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy","volume":"22","author":"Dunn","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ajpath.2024.01.011_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2024.01.011_bib29","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.01.011_bib30","article-title":"Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels","volume":"119","author":"Liu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.01.011_bib31","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1136\/gutjnl-2021-325137","article-title":"Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT","volume":"71","author":"Tian","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.01.011_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00062.2021","article-title":"Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases","volume":"103","author":"Herre","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2024.01.011_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cns.13382","article-title":"RGS16 promotes glioma progression and serves as a prognostic factor","volume":"26","author":"Huang","year":"2020","journal-title":"CNS Neurosci Ther"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T12:20:54Z","timestamp":1714306854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0002944024000427"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.01.011","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}